- Research works
- 96 ▼ 17% vs 2013–17
- Citations
- 3.6k 37.1 per fractional work
- Top-10% rate
- 14.5% record average 16.5%
- Open access
- 42% world 28%
Not ranked overall: Alphabio is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 9.3×. Every wedge is a field page.
- Immunology and Microbiology 9.3×
- Chemical Engineering 3.6×
- Medicine 3.1×
- Biochemistry, Genetics and Molecular Biology 2.5×
- Pharmacology, Toxicology and Pharmaceutics 2.4×
- Chemistry 1.7×
- Neuroscience 0.6×
- Agricultural and Biological Sciences 0.6×
- Environmental Science 0.5×
- Business, Management and Accounting 0.4×
- Physics and Astronomy 0.3×
- Psychology 0.2×
- Social Sciences 0.1×
- Engineering 0.1×
- Health Professions 0.1×
- Computer Science 0.1×
- Economics, Econometrics and Finance 0.1×
Who are the top researchers at Alphabio?
Ranked on the composite score, Philippe Halfon, Hacène Khiri and Guillaume Pénaranda lead among researchers whose main affiliation is Alphabio.
- 1 Philippe Halfon France · #481,727 worldwide 104 citations · 52 works
- 2 Hacène Khiri France · #689,999 worldwide 38 citations · 16 works
- 3 Guillaume Pénaranda France · #1,008,574 worldwide 28 citations · 30 works
Which keywords describe research at Alphabio?
By fractional works in all years, weighted toward what it does more of than the world: Immune Response, Epidemiology, Antiviral Therapy, Liver Disease, Hepatocellular Carcinoma, Treatment, Genetic Variation and Hepatitis C Virus.
- Survival
- Clinical Practice Guidelines
- AIDS
- Pathogenesis
- HPV Vaccination
- Cytology Screening
- Nucleoside Analogues
- Drug Resistance
- Cervical Cancer
- Management
- Diagnosis
- Vaccine
- NAFLD
- Chronic Hepatitis B
- Antiretroviral Therapy
- Global Burden
- Hepatitis C Virus
- Treatment
- Liver Disease
- Immune Response
- Epidemiology
- Antiviral Therapy
- Hepatocellular Carcinoma
- Genetic Variation
- Ribavirin
- Insulin Resistance
- Metabolic Syndrome
- Hepatitis B Virus
- NASH
- Inflammation
- HIV Infection
- Human Papillomavirus
- Cancer Incidence
- Integrase Inhibitors
- HIV
- HIV Transmission
- Immune Activation
- Viral Oncoproteins
- Antibodies
- Pregnancy
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology23▲ 6.0×41 topics
- Immune Response21▲ 36×12 topics
- Antiviral Therapy17▲ 118×3 topics
- Liver Disease17▲ 129×2 topics
- Hepatocellular Carcinoma14▲ 70×3 topics
- Treatment13▲ 11×13 topics
- Genetic Variation11▲ 36×5 topics
- Hepatitis C Virus10▲ 206×1 topic
- Ribavirin10▲ 206×1 topic
- Global Burden9▲ 18×4 topics
- Insulin Resistance8▲ 17×5 topics
- Antiretroviral Therapy8▲ 34×4 topics
- Metabolic Syndrome7▲ 8.4×7 topics
- Chronic Hepatitis B7▲ 133×1 topic
- Hepatitis B Virus7▲ 133×1 topic
- NAFLD6▲ 59×1 topic
- NASH6▲ 59×1 topic
- Vaccine6▲ 14×8 topics
- Inflammation4▲ 1.84×25 topics
- Diagnosis4▲ 3.9×11 topics
- HIV Infection4▲ 32×2 topics
- Management4▲ 4.7×8 topics
- Human Papillomavirus3▲ 28×3 topics
- Cervical Cancer3▲ 34×3 topics
- Cancer Incidence3▲ 21×3 topics
- Drug Resistance3▲ 9.3×2 topics
- Integrase Inhibitors3▲ 69×1 topic
- Nucleoside Analogues3▲ 69×1 topic
- HIV3▲ 24×2 topics
- Cytology Screening3▲ 53×1 topic
- HIV Transmission3▲ 32×2 topics
- HPV Vaccination3▲ 53×1 topic
- Immune Activation3▲ 29×2 topics
- Pathogenesis3▲ 4.9×10 topics
- Viral Oncoproteins3▲ 38×2 topics
- AIDS2▲ 48×1 topic
- Antibodies2▲ 29×1 topic
- Clinical Practice Guidelines2▲ 4.4×5 topics
- Pregnancy2▲ 10×4 topics
- Survival2▲ 16×2 topics
Which research topics does Alphabio publish most on?
By volume in 2022–2025: Reproductive Biology and Fertility, Cholangiocarcinoma and Gallbladder Cancer Studies, Reproductive tract infections research and Gastrointestinal motility and disorders.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Reproductive Biology and Fertility Public Health, Environmental and Occupational Health 0 works
- 2 Cholangiocarcinoma and Gallbladder Cancer Studies Surgery 0 works
- 3 Reproductive tract infections research Microbiology 0 works
- 4 Gastrointestinal motility and disorders Gastroenterology 0 works
- 5 COVID-19 Clinical Research Studies Infectious Diseases 0 works
- 6 Hepatocellular Carcinoma Treatment and Prognosis Hepatology 0 works
- 7 Extracellular vesicles in disease Molecular Biology 0 works
- 8 vaccines and immunoinformatics approaches Molecular Biology 0 works
- 9 Inflammatory Bowel Disease Genetics 0 works
- 10 Hepatitis B Virus Studies Epidemiology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Alphabio's research output changed?
Output in 2018–2022 was 17% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Marseille
- Aix-Marseille Université
- Institut de Recherche pour le Développement
- Hôpital de la Timone
- Hôpital Nord
- Institut de Neurobiologie de la Méditerranée
- Hôpital Sainte-Marguerite
- Hôpital Européen
- Hôpital de la Conception
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.